tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

IQV Stock Latest News

Iqvia price target raised to $265 from $235 at Truist
The FlyIqvia price target raised to $265 from $235 at Truist
6h ago
IQV
Iqvia price target raised to $254 from $234 at Stifel
PremiumThe Fly
Iqvia price target raised to $254 from $234 at Stifel
7h ago
IQV
Iqvia price target raised to $250 from $225 at UBS
PremiumThe Fly
Iqvia price target raised to $250 from $225 at UBS
7h ago
IQV
Iqvia price target raised to $255 from $177 at JPMorgan
PremiumThe Fly
Iqvia price target raised to $255 from $177 at JPMorgan
9h ago
IQV
Iqvia price target raised to $230 from $200 at Citi
PremiumThe Fly
Iqvia price target raised to $230 from $200 at Citi
10h ago
IQV
Iqvia upgraded to Outperform from Neutral at Baird
PremiumThe FlyIqvia upgraded to Outperform from Neutral at Baird
12h ago
IQV
IQVIA Holdings Reports Strong Q3 2025 Results
Premium
Company Announcements
IQVIA Holdings Reports Strong Q3 2025 Results
16h ago
IQV
IQVIA Holdings: Strong Earnings and Strategic Growth
Premium
Company Announcements
IQVIA Holdings: Strong Earnings and Strategic Growth
20h ago
IQV
Iqvia sees Q4 adjusted EPS $3.35-$3.45, consensus $3.39
PremiumThe Fly
Iqvia sees Q4 adjusted EPS $3.35-$3.45, consensus $3.39
1d ago
IQV
IQVIA Holdings: Hold Rating Amid Stable Performance and Limited Upside Potential
PremiumRatings
IQVIA Holdings: Hold Rating Amid Stable Performance and Limited Upside Potential
1d ago
IQV
Resilient Growth and Strong Segment Performance Drive Buy Rating for IQVIA Holdings
PremiumRatings
Resilient Growth and Strong Segment Performance Drive Buy Rating for IQVIA Holdings
1d ago
IQV
Iqvia narrows FY25 adjusted EPS view to $11.85-$11.95 from $11.75-$12.05
PremiumThe Fly
Iqvia narrows FY25 adjusted EPS view to $11.85-$11.95 from $11.75-$12.05
1d ago
IQV
Iqvia reports Q3 adjusted EPS $3.00, consensus $2.98
PremiumThe FlyIqvia reports Q3 adjusted EPS $3.00, consensus $2.98
1d ago
IQV
Cenobamate’s Real-World Impact: A New Hope for Focal Epilepsy?
Premium
Company Announcements
Cenobamate’s Real-World Impact: A New Hope for Focal Epilepsy?
2d ago
IQV
IQVIA’s Latest Clinical Study Update: A Game Changer in Cardiovascular Treatment?
Premium
Company Announcements
IQVIA’s Latest Clinical Study Update: A Game Changer in Cardiovascular Treatment?
2d ago
IQV
IQVIA’s Innovative Approach: The Carry Life UF System Study Update
PremiumCompany Announcements
IQVIA’s Innovative Approach: The Carry Life UF System Study Update
2d ago
IQV
IQVIA’s Latest Clinical Study on NOC-110: A Potential Game-Changer for Chronic Cough
PremiumCompany Announcements
IQVIA’s Latest Clinical Study on NOC-110: A Potential Game-Changer for Chronic Cough
2d ago
IQV
IQVIA’s Latest Clinical Study Update: A New Hope for Peripheral Arterial Disease
PremiumCompany Announcements
IQVIA’s Latest Clinical Study Update: A New Hope for Peripheral Arterial Disease
2d ago
IQV
IQVIA and Swedish Orphan Biovitrum’s PNH Study: A Potential Game-Changer for Pegcetacoplan
PremiumCompany Announcements
IQVIA and Swedish Orphan Biovitrum’s PNH Study: A Potential Game-Changer for Pegcetacoplan
2d ago
IQV
QUVIVIQ® Pregnancy Registry: Insights into Insomnia Treatment During Pregnancy
PremiumCompany AnnouncementsQUVIVIQ® Pregnancy Registry: Insights into Insomnia Treatment During Pregnancy
2d ago
IQV
IQV Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
IQV Earnings Report this Week: Is It a Buy, Ahead of Earnings?
3d ago
IQV
Oracle initiated, Roblox upgraded: Wall Street’s top analyst calls
Premium
The Fly
Oracle initiated, Roblox upgraded: Wall Street’s top analyst calls
20d ago
BE
GPK

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >